Sai Life Sciences
add_icon

Sai Life Sciences

973.55
+27.90
(2.95%)
Market Cap
20,616.69 Cr
PE Ratio
60.15
Volume
4,09,759.00
Day High - Low
984.20 - 959.20
52W High-Low
1,084.00 - 636.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
20,616.69 Cr
EPS
8.83
PE Ratio
60.15
PB Ratio
8.82
Book Value
107.18
EBITDA
442.40
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
7.99
Debt to Equity
0.42
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Sai Life Sciences Limited submitted mandatory regulatory certificate under SEBI Depositories Regulations for quarter ended March 31, 2026, confirming compliance with dematerialization requirements.
positive
Morgan Stanley Upgrades Sai Life Sciences Target to ₹1,16022 hrs ago
Morgan Stanley maintains Overweight rating, raises target price from ₹1,123 to ₹1,160 on earnings upgrades, strong discovery segment growth, and improved CDMO demand visibility.
positive
Sai Life Sciences Limited announces appointment of Dr. John Pavey as Senior Management Personnel effective 1 April 2026, replacing retiring Dr. Dean David Edney as Head of Global PR&D.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,714.60
#1 4,11,389.97
37.65
#1 54,729.00
9.71
#1 10,980
16.07
42.98
5,882.00
1,56,148.62
62.64
9,712.00
18.67
2,191
-1.02
37.15
4,029.20
1,36,366.44
60.32
11,539.40
6.99
1,911
26.24
37.30
2,294.10
1,04,850.28
22.49
22,909.50
13.74
3,306
#1 37.44
50.67
1,191.40
99,439.37
18.08
33,741.20
16.73
5,725
-15.28
35.49
1,215.90
98,218.05
21.42
28,409.50
7.12
5,291
-57.18
35.83
891.55
89,710.79
#1 17.49
23,511.00
18.55
4,615
-0.32
50.58
2,041.90
84,290.67
46.71
12,744.20
#1 20.90
2,007
7.65
46.83
1,335.70
77,577.67
22.16
32,345.60
9.43
3,484
7.59
63.41
5,246.00
62,723.80
25.49
13,458.30
3.70
2,216
1.90
43.47
Growth Rate
Revenue Growth
15.86 %
Net Income Growth
105.43 %
Cash Flow Change
19.37 %
ROE
-5.89 %
ROCE
-1.49 %
EBITDA Margin (Avg.)
21.38 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
395
443
288
406
449
589
506
553
565
Expenses
287
315
254
293
320
422
376
392
377
EBITDA
108
128
34
112
129
167
131
161
188
Operating Profit %
25 %
28 %
9 %
26 %
27 %
27 %
24 %
27 %
32 %
Depreciation
31
31
31
36
34
38
38
40
44
Interest
23
21
21
21
23
11
12
9
10
Profit Before Tax
53
76
-18
55
72
119
81
112
134
Tax
13
20
-5
14
18
31
20
28
34
Net Profit
40
56
-14
42
54
88
61
84
100
EPS in ₹
2.19
31.00
-0.74
2.22
2.89
4.24
2.90
4.01
4.77

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,216
1,410
1,817
2,157
2,177
2,275
3,160
Fixed Assets
374
641
701
751
789
1,180
1,488
Current Assets
691
613
804
944
962
945
1,505
Capital Work in Progress
116
91
246
410
399
107
125
Investments
0
0
0
0
2
2
2
Other Assets
726
679
870
997
987
987
1,545
Total Equity & Liabilities
1,216
1,410
1,817
2,157
2,177
2,275
3,160
Current Liabilities
336
467
599
713
757
740
733
Non Current Liabilities
160
149
356
565
532
560
299
Total Equity
720
794
863
879
888
975
2,128
Reserve & Surplus
703
777
845
861
870
957
2,108
Share Capital
16
16
18
18
18
18
21

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
239
-150
-1
75
-80
-24
79
Investing Activities
-158
-262
-260
-102
-99
-191
-536
Operating Activities
129
116
-36
105
219
263
314
Financing Activities
268
-4
296
72
-201
-95
301

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
39.64 %
35.24 %
35.24 %
35.17 %
35.15 %
34.94 %
34.70 %
FIIs
0.00 %
7.64 %
11.72 %
12.36 %
14.58 %
22.50 %
21.40 %
DIIs
0.00 %
5.61 %
11.95 %
13.26 %
21.64 %
29.91 %
31.41 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.68 %
8.88 %
7.69 %
6.56 %
7.91 %
5.95 %
Others
60.36 %
32.84 %
32.22 %
31.52 %
22.07 %
4.74 %
6.54 %
No of Share Holders
70
5,72,970
82
1,40,677
1,26,380
1,19,705
1,14,820

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 695.75 694.80
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 May 2025 717.70 713.35
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 815.20 792.85
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Sept 2025 791.55 861.70
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 892.85 923.20
05 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2026 808.30 810.00

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201815 hrs ago
Announcement under Regulation 30 (LODR)-Change in Management9 days ago
Closure of Trading Window9 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 24, 2026
Intimation Of An Order Dated 18Th March 2026 Passed By The Deputy Commissioner Of Income Tax (International Taxation) Hyderabad U/S 201 (1) Of The Income Tax Act 1961Mar 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 26, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 26, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 05, 2026
Unaudited Financial Results (Standalone And Consolidated) For The Third Quarter And Nine Months Ended On 31 December 2025.Feb 05, 2026
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended On 31 December 2025.Feb 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For The Third Quarter And Nine Months Ended December 31 2025.Jan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Intimation Of Receipt Of Letter From BSE Dated 06 January 2026 And NSE Dated 07 January 2026.Jan 07, 2026
Receipt Of An Order Dated 30Th December 2025 Passed By The Additional Commissioner Ranga Reddy GST Commissionerate Hyderabad U/S 74 Of The Central Goods And Services Tax Act 2017Dec 31, 2025
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 19, 2025
An Order Dated 09Th December 2025 Was Passed By The Deputy Commissioner Of Commercial Taxes (Audit) Bidar DGSTO Kalaburagi U/S 73(9) Of The Integrated Goods And Services Tax Act 2017.Dec 11, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 08, 2025
An Order Dated 06Th December 2025 Has Been Passed By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi Under Section 107(11) Of The Karnataka Goods And Services Tax Act 2017.Dec 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 23, 2025
Intimation For Order Dated 19Th November 2025 Issued By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi U/S 107 (11) Of The Karnataka Goods And Services Tax Act 2017 And The Central Goods And Services Tax Act 2017.Nov 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Intimation Of Order Dated 12Th November 2025 Passed By The Assistant Commissioner Central Tax Division-II (Pimpri) Pune-I Commissionerate U/S 74 Of The CGST Act 2017.Nov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended On 30 September 2025Nov 06, 2025
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended On 30 September 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30 September 2025.Oct 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 17, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Innovation Fund Direct-Growth
0.00%
-413214
-1.61%
-1.33%
Nippon India MNC Fund Direct-Growth
0.00%
-125000
-2.93%
-2.45%
Bandhan Healthcare Fund Direct-Growth
0.00%
-60000
-2.03%
-1.79%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-18714
-0.72%
-0.60%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.00%
-1651
-0.24%
0.00%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-1058
-0.10%
0.00%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-673
-0.71%
-0.60%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-381
-0.07%
-0.06%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.00%
-242
-0.24%
-0.20%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-78
-0.07%
-0.06%
ITI Pharma and Healthcare Fund Direct-Growth
0.00%
0
0.00%
-1.78%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.72%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
0.00%
0
0.00%
-2.16%
Aditya Birla Sun Life Retirement Fund - The 40s Plan Direct-Growth
0.00%
0
0.00%
-1.30%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.00%
0
0.00%
-2.63%
Angel One Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Axis Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
-0.87%
Axis India Manufacturing Fund Direct-Growth
0.00%
0
0.00%
-0.52%
Axis Innovation Fund Direct-Growth
0.00%
0
0.00%
-2.08%
Axis Multicap Fund Direct-Growth
0.00%
0
0.00%
-0.87%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Axis Small Cap Fund Direct-Growth
0.00%
0
0.00%
-1.45%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-1.00%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
-1.24%

Technical Indicators

RSI(14)
Neutral
43.57
ATR(14)
Less Volatile
38.26
STOCH(9,6)
Neutral
24.22
STOCH RSI(14)
Oversold
0.56
MACD(12,26)
Bearish
-9.98
ADX(14)
Weak Trend
10.19
UO(9)
Bearish
45.96
ROC(12)
Downtrend And Accelerating
-4.11
WillR(14)
Oversold
-81.90